samedan logo
 
 
spacer
home > pmps > summer 2021 > big change in the cold chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Big Change in the Cold Chain

PMPS: Pharmaceutical logistics have come under huge pressure throughout the COVID-19 pandemic. How do you feel the industry as a whole has dealt with the situation?

Marcel Kuijn: The outbreak of the pandemic has had an unprecedented impact on the industry. From one day to the other, airlines had to ground almost their entire passenger fleet and crucial logistical flows came to a halt. Immediately, you saw that the industry started to look for alternative solutions. On the airline side, this meant flying passenger aircrafts only with cargo, carrying cargo in cabin, and/or converting passenger aircraft to freighters. The industry has shown significant agility and creativity, but it has also put pressure on the teams. They have had to work hard to make this happen, and often in difficult circumstances due to the restrictions in place.

an airline was that the quantity of dry ice used for the vaccine transport was higher than what we normally see. This meant that we had to make sure that we could transport large quantities in a safe way, whereby the sublimation rate of dry ice was a key factor.

Deciding between dry ice and other cold chain solutions has been a talking point during the pandemic, what are the benefits of using these methods for air cargo?

We have seen that, for the transportation of COVID-19 vaccines, a range of cold chain solutions are being used from 2-8°C temperature-controlled products to active and hybrid containers and dry ice. The deep-frozen temperatures required for some of the vaccines meant that there were not any other options than dry ice. Dry ice is a dangerous good, and requires specific measures to ensure safety on the ground and in the air. The main challenge we had to work on as an airline was that the quantity of dry ice used for the vaccine transport was higher than what we normally see. This meant that we had to make sure that we could transport large quantities in a safe way, whereby the sublimation rate of dry ice was a key factor.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Marcel Kuijn has a Master’s degree in Business Administration from the Erasmus University in Rotterdam, The Netherlands. He joined KLM in 2002 and gained commercial and operational experience in various managerial positions at KLM, Air France-KLM, and its Cargo division. Marcel joined Cargo in 2016 as Director of Pricing. In his current position, Marcel is responsible worldwide for the pharmaceutical business at Air France KLM Martinair Cargo. He previously held positions at various passenger division departments, including Digital Marketing and Global Account Management. Before joining Cargo in 2016, he was Commercial Director of South America for Air France-KLM.
spacer
Marcel Kuijn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mogrify and Astellas Announce Collaboration to Conduct Research on In Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss

Cambridge, UK, Tokyo, Japan, 05 July 2022: Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

Connect in Pharma

14-15 September 2022, Plaexpo, Geneva, Switzerland

The new event driving innovation for pharma and biopharma businesses, Connect in Pharma will unite key players in Pharmaceutical and Biopharmaceutical packaging and production in Geneva on 14 – 15 September 2022.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement